The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Iosifescu, D. V.
* Articles by Fava, M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Iosifescu, D. V.
* Articles by Fava, M.
Related Collections
* Depression
* Antidepressants
Am J Psychiatry 160:2122-2127, December 2003
© 2003 American Psychiatric Association


Article

The Impact of Medical Comorbidity on Acute Treatment in Major Depressive Disorder

Dan V. Iosifescu, M.D., Andrew A. Nierenberg, M.D., Jonathan E. Alpert, M.D., Megan Smith, B.A., Stella Bitran, B.A., Christina Dording, M.D., and Maurizio Fava, M.D.

OBJECTIVE: The authors investigated the impact of medical comorbidity on the acute phase of antidepressant treatment in subjects with major depressive disorder. METHOD: A total of 384 outpatients meeting DSM-III-R criteria for major depressive disorder enrolled in 8-week open treatment with fluoxetine, 20 mg/day. The authors used the Cumulative Illness Rating Scale to measure the burden of medical comorbidity and the 17-item Hamilton Rating Scale for Depression to assess changes in depressive symptoms. The outcome measures were response to treatment (>=50% reduction in score) and clinical remission (score <=7 at the end of the trial). RESULTS: Compared to responders to fluoxetine, nonresponders had significantly higher Cumulative Illness Rating Scale scores and a greater number of Cumulative Illness Rating Scale categories were endorsed. Compared to subjects who achieved remission with antidepressant treatment, those who did not achieve remission had significantly higher Cumulative Illness Rating Scale scores and a greater number of Cumulative Illness Rating Scale categories were endorsed (i.e., more organs were affected by medical illness). The final Hamilton depression scale score was directly correlated with the total Cumulative Illness Rating Scale score and the number of Cumulative Illness Rating Scale categories endorsed. CONCLUSIONS: The total burden of medical illness and the number of organ systems affected by medical illness had a significantly negative predictive value for clinical outcome in the acute phase of treatment in major depressive disorder.




This article has been cited by other articles:


Home page
Psychosom. Med.Home page
R. Lieb, G. Meinlschmidt, and R. Araya
Epidemiology of the Association Between Somatoform Disorders and Anxiety and Depressive Disorders: An Update
Psychosom Med, November 1, 2007; 69(9): 860 - 863.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
R. Fraguas Jr., D. V. Iosifescu, J. Alpert, S. R. Wisniewski, J. L. Barkin, M. H. Trivedi, A J. Rush, and M. Fava
Major Depressive Disorder and Comorbid Cardiac Disease: Is There a Depressive Subtype With Greater Cardiovascular Morbidity? Results From the STAR*D Study
Psychosomatics, October 1, 2007; 48(5): 418 - 425.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
P. L. Kimmel and R. A. Peterson
Depression in Patients with End-Stage Renal Disease Treated with Dialysis: Has the Time to Treat Arrived?
Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 349 - 352.
[Full Text] [PDF]


Home page
JAMAHome page
C. Salzman
A 60-Year-Old Woman Who Has Felt Sad for Much of Her Life
JAMA, January 18, 2006; 295(3): 318 - 323.
[Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. H. Trivedi, A. J. Rush, S. R. Wisniewski, A. A. Nierenberg, D. Warden, L. Ritz, G. Norquist, R. H. Howland, B. Lebowitz, P. J. McGrath, et al.
Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice
Am J Psychiatry, January 1, 2006; 163(1): 28 - 40.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
A. J. Mitchell and H. Subramaniam
Prognosis of Depression in Old Age Compared to Middle Age: A Systematic Review of Comparative Studies
Am J Psychiatry, September 1, 2005; 162(9): 1588 - 1601.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
D. V. Iosifescu, A. A. Nierenberg, J. E. Alpert, M. Smith, S. Bitran, C. Dording, and M. Fava
The Impact of Medical Comorbidity on Acute Treatment in Major Depressive Disorder
Focus, January 1, 2005; 3(1): 69 - 75.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. B. Stein, C. D. Sherbourne, M. G. Craske, A. Means-Christensen, A. Bystritsky, W. Katon, G. Sullivan, and P. P. Roy-Byrne
Quality of Care for Primary Care Patients With Anxiety Disorders
Am J Psychiatry, December 1, 2004; 161(12): 2230 - 2237.
[Abstract] [Full Text] [PDF]


Home page
JWatch PsychiatryHome page
Medical Comorbidity Complicates Depression Treatment
Journal Watch Psychiatry, March 25, 2004; 2004(325): 13 - 13.
[Full Text]


Home page
JWatch Women's HealthHome page
Medical Comorbidity Complicates Depression Treatment
Journal Watch Women's Health, February 11, 2004; 2004(211): 8 - 8.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org